迪恩ोजे斯特减弱了卵巢子宫内膜瘤囊中的STAT3激活
JongYeob Choi1, MinWha Jo2, EunYoung Lee1
1Infertility Clinic, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.
European journal of obstetrics, gynecology, and reproductive biology
|February 1, 2024
概括
在子宫内膜异位症中,dienenogest治疗可以减少过度的信号传感器和转录3 (STAT3) 激活器激活. 这种抑制会影响细胞增殖,侵袭和细胞亡,为子宫内膜异位症提供潜在的治疗途径.
科学领域:
- 生殖生物学 生殖生物学
- 分子内分泌学分子内分泌学
- 妇科疾病中的细胞机制
背景情况:
- 子宫内膜异位症与过度活跃的信号传感器和转录3 (STAT3) 信号的激活器有关.
- STAT3调节关键的细胞过程,包括增殖,入侵和亡.
- 针对STAT3激活可能是子宫内膜异位症的治疗策略.
研究的目的:
- 为了研究是否通过调节STAT3激活来调节dienogest的抗子宫内膜异位作用.
- 评估dienogest对子宫内膜异位症中STAT3信号传递的影响.
主要方法:
- 在正常的子宫内膜和子宫内膜组织中评估了STAT3激活,这些患者接受了/没有接受dienogest治疗.
- 通过使用子宫内膜囊干细胞 (ECSC) 进行了体外研究,以证实dienogest对STAT3激活的直接作用.
- 评估PCNA,MMP-2和BCL-2的蛋白质表达.
主要成果:
- 与正常组织相比,未经治疗的子宫内膜组织中的STAT3激活显著更高.
- 在手术前给予二氧化物剂可逆转STAT3激活的升高.
- 迪埃诺格斯特抑制了ECSC中IL-6刺激的STAT3激活,降低了PCNA,MMP-2和BCL-2的表达.
结论:
- 迪埃诺杰斯特有效地抑制了子宫内膜瘤囊细胞中的STAT3激活.
- 这种抑制会影响细胞增殖,侵入性和子宫内膜异位症中细胞亡.
- 迪昂格斯特的作用机制涉及STAT3信号通路的调节.
相关概念视频
02:07Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
01:22Hormonal Regulation of the Menstrual Cycle
391
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
391
01:27Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
01:30Hormonal Control of the Ovarian Cycle
514
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
514